Latest Abagovomab Stories
Biovest International, a majority-owned subsidiary of Accentia Biopharmaceuticals, has announced clinically and statistically significant unblinded data from its randomized controlled pivotal Phase III fast-tracked clinical trial of BiovaxID for the treatment of indolent follicular non-Hodgkin's lymphoma, an often fatal blood cancer.
By Jason Gertzen, The Kansas City Star, Mo. Jun. 27--Local ovarian cancer patients soon will begin receiving new treatments, signaling advances both in the fight against the disease and in the region's bioscience aspirations.
AVAX Technologies, Inc. (OTCMarket:AVXT.OB) today announces it has executed a collaboration and production agreement with Cancer Treatment Centers of America, Inc.
By Ransdell Pierson NEW YORK (Reuters) - The U.S.
By Gene Emery BOSTON (Reuters) - Injecting anti-cancer drugs into the body cavity, not just into a vein, can dramatically lengthen the lives of women with advanced ovarian cancer, a study showed on Wednesday. The U.S.
NEW YORK (Reuters Health) - A study of women with advanced endometrial cancer has found that giving two chemotherapy drugs after surgery reduced the risk of recurrence by 29 percent and extended survival by 32 percent compared with radiation therapy.
A clinical study of ovarian cancer initiated by investigators at Yale School of Medicine will combine the anti-cancer drug phenoxodiol with docetaxel for women with recurrent ovarian cancer.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.